HANGZHOU BIOTEST BIOTECH CO.(SH:688767) Sou Hu Cai Jing·2026-01-28 09:47Core Insights - The National Medical Products Administration of China has approved two industry standards for medical devices utilizing brain-computer interface (BCI) technology, indicating a push for high-quality development in this sector [1] - Analysts believe that the BCI field is entering a critical window for expansion from research validation to clinical and consumer applications, driven by recent innovative policies in medical devices [1] Industry Overview - Neuralink, founded by Elon Musk, is a leading player in the global BCI field, planning to scale up production of BCI devices and explore automated surgical solutions [3] - The global BCI market is projected to reach approximately $2.6 billion in 2024, with an annual growth rate of 11.5%, and is expected to expand to $3.3 billion by 2026 [3] - McKinsey forecasts that the BCI market in the medical sector could reach around $40 billion by 2030 and further grow to about $145 billion by 2040, with central nervous system disease treatment as a primary application area [3] Domestic Development - China's top-level policy design is providing crucial support for the development of BCI technology, with a goal to achieve breakthroughs in key technologies and establish a standard system by 2027 [4] - The number of companies in China's BCI sector has exceeded 200, with a projected industry scale of tens of billions of RMB by 2026 and an estimated 10-14 billion RMB by 2030 [4] - Rumors suggest that Qiangnao Technology is preparing for an IPO in Hong Kong, potentially becoming the first company among the "Hangzhou Six Little Dragons" to enter the capital market [4] Company Activities - In the A-share market, there are currently 50 listed companies in the BCI sector [5] - Botao Biological has invested in Haoshi Tianhui Technology, focusing on non-invasive BCI and mental health applications, aiming to accelerate clinical transformation and industrialization of innovative technologies [5] - Tianqi Co., Ltd. is entering the core BCI sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, which is crucial for domestic BCI hardware localization [6] - Innovation Medical is positioning itself in the BCI industry through its subsidiary Boling Brain Machine, which has commercialized BCI rehabilitation products [6]